Trial
NCT00299988
Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
Baxter BioScience; National Institutes of Health (NIH)
Condition
Alzheimer's Disease
Intervention
Intravenous Immunoglobulin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-11